Mergers & Acquisitions in Pharma Industry

Topics: GlaxoSmithKline, Mergers and acquisitions, Pharmaceutical industry Pages: 79 (21441 words) Published: April 14, 2012
A Successful International Merger in India:
GlaxoSmithKline pharmaceutical industry

Table of Contents:

Part I –Introduction
Research Objective and justifications
Report Outline
Part-II Industry Description
GSK-The Big Picture
Factors for success in India
Part-III Literature review
Chapter One –Merger: An Introduction
1.1 Introduction
1.2 The Main Idea
1.3 Types of Merger
1.4 Reasons for International M&A
Chapter Summary
Chapter Two-Nature of Indian pharmaceutical
Industry 2.1 Introduction
2.2 Nature of Indian Pharmaceutical Industry
2.2.1 Industry Scenario
2.2.2 Market Scenario ((Projected Pharmaceutical Market, 2004-2009))
2.2.3 New Product Launches underlie market growth
2.2.5 Key Opportunities
2.2.6 FDI in Indian pharma
2.2.7 Strategy and Trends
2.2.8 Research and Development
2.2.9 SWOT Analysis
2.2.10 Mergers and Acquisitions in Pharma
2.2.11 Good Opportunities for ‘big pharma’
Chapter Three-Merger between Glaxo Wellcome
Smithkline Beecham
3.1 Introduction
3.2 Merger rationale
3.2.1 Rapid advances in Science and Technology
3.2.2 The growing importance of marketing power
3.2.3 The emergence of patients as consumers
3.3 Merger Benefits
3.3.1 Short term growth
3.3.2 Medium term growth
3.3.3 Long term growth
3.4 Business performance of GSK
Chapter summary
Chapter Four-Research Methodology
4.1 Introduction
4.2 Primary Research
4.3 Secondary Research
4.4 Sources of Information
4.5 Research design
4.6 Qualitative research
4.7 Exploratory research
4.8 Data Collection Technique
4.8.1 Primary Data
4.8.2 Exploratory Research Design Secondary Data
4.8.3 Computerized Database
4.8.4 The Interview
4.9 Limitations of study
Chapter Five –Factors that support the research
5.1 Introduction
5.2 Foreign Direct Investment
5.2.1 Forms of FDI
Chapter Summary

Chapter Six-Research Findings
6.1 Introduction
6.2 About R&D of GlaxoSmithKline
6.2.1 Research Design
6.2.2 Discovering new medicines
6.2.3 Genetic Research
6.2.4 Discovery Research
6.2.5 Drug Discovery
6.2.6 Pre-Clinical Development
6.2.7 Global Commercial Strategy
6.2.8 Clinical Trails
6.2.9 Collaboration and Partnership
6.2.10 Big Pharma to launch patent protected products in India
6.2.11 Technology, Absorption, Adaptions and Innovation
6.2.12 R&D centers in India
6.2.13 Expenditure on R&D
6.3 Product making- By GSK
6.3.1 Collaboration with Galapagos
6.3.2 Collaboration with Path
6.3.3 Collaboration with IAVI
6.3.4 H5NI avian flu Strain
6.3.5 For HIV/AIDS
6.3.6 Vaccine launchers
6.3.7 Pharmaceutical Products (Progress in 2009)
6.3.8 Available products in India
6.4 Marketing strategy of GlaxoSmithKline
Chapter Summary

Chapter Seven – Discussion & Analysis
7.1 Introduction
7.2 Merger-Boom or Bane
7.3 Analysis//Summary
7.3.1 Rationale
7.3.2 Schemes of arrangement
7.3.3 Results of the implementation of Merger
7.3.4 Foreign exchange earnings and outgo of GlaxoSmithKline
Annexure A-Questionnaire...
Continue Reading

Please join StudyMode to read the full document

You May Also Find These Documents Helpful

  • Mergers and Acquisitions Essay
  • merger and acquisition Essay
  • Mergers and Acquisitions in Indan Industry Essay
  • Merger and Acquisition Essay
  • Mergers and Acquisitions Essay
  • Mergers And Acquisitions Essay
  • Mergers and Acquisitions Essay

Become a StudyMode Member

Sign Up - It's Free